← Back to Search

Antiretroviral

Intervention Recipients for Behavioral Mechanisms

N/A
Waitlist Available
Led By Sybil Hosek, PhD
Research Sponsored by Hektoen Institute for Medical Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 weeks
Awards & highlights

Study Summary

This trial will study the safety of pre-exposure prophylaxis (PrEP) for transgender youth.

Eligible Conditions
  • Behavioral Mechanisms
  • Gender
  • HIV/AIDS

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
PrEP Acceptability Questionnaire
Tenofovir diphosphate levels

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention RecipientsExperimental Treatment1 Intervention
PrEP Demonstration Project intervention will be given
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PrEP Demonstration Project
2022
N/A
~60

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,785 Previous Clinical Trials
2,689,705 Total Patients Enrolled
Hektoen Institute for Medical ResearchLead Sponsor
8 Previous Clinical Trials
7,681 Total Patients Enrolled
Sybil Hosek, PhDPrincipal InvestigatorCook County Health
10 Previous Clinical Trials
768 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~17 spots leftby Apr 2025